Acamprosate vs naltrexone: How do they compare?
Acamprosate and naltrexone are two different medications that are used in the treatment of alcohol use disorder. They work in different ways to help people who are dependent on alcohol to abstain from drinking it. Naltrexone is also used for the treatment of opioid use disorder.
Acamprosate was thought to be slightly more effective at helping people with alcohol use disorder remain off alcohol, while naltrexone was thought to be slightly more effective at helping reduce heavy drinking and cravings, according to the results of a meta-analysis which used data from 64 trials.
Results from a small study comparing the two drugs, however, indicates that naltrexone was more effective than acamprosate in a number of areas. The study was conducted in 157 men who had recently undergone alcohol detoxification,
The study found there was no difference in the average time to first drink, but naltrexone recipients had a significantly longer time to relapse (five or more drinks in a day) than acamprosate recipients (63 vs 42 days; p = 0.02). Also, more naltrexone recipients had not relapsed after one year compared with acamprosate recipients (41% vs 17%; p = 0.0009). The number of days participants remained sober was also higher in the naltrexone group, while the number of drinks they had at one time and the severity of their cravings was significantly less (p = 0.038). More participants in the acamprosate group than the naltrexone group were started on disulfiram during the study period.
Another study conducted in 160 participants with alcoholism also noted that naltrexone treatment tended to result in longer times to first drink and relapse compared with acamprosate treatment.
Acamprosate | Naltrexone | |
---|---|---|
Dosage Form | | |
Generic / brand names | | |
FDA approval date | 2004 | 1984 (tablet) 2006 (extended-release intramuscular injection) |
Administration | | |
Dosing schedule | | |
Indication / usage | Acamprosate should be used as part of a comprehensive management program that includes psychosocial support. Acamprosate is not used to help the symptoms of alcohol withdrawal. | You should stop drinking alcohol or using opioids before starting naltrexone. |
Drug type | A small molecule analog of gamma-aminobutyric acid (GABA) and taurine | A small molecule opioid antagonist |
Mechanism of action | The exact mechanism is unclear, but it’s thought to work by targeting GABA and N-methyl-D-aspartate (NMDA) | Opioid antagonist |
Side effects / adverse effects | Common adverse events that occurred in 3% or greater (and greater than the placebo group in controlled clinical trials) of patients include: | Common adverse events that occur in more than 10% of patients being treated for alcohol use disorder with naltrexone tablets include: Common adverse events that occurred in more than 10% of patients being treated for opioid addiction with naltrexone tablets include: |
Warnings and precautions | | |
Special patients populations | | |
Related medical questions
- Acamprosate vs naltrexone: How do they compare?
- Does acamprosate make you sick if you drink alcohol?
- How long does it take for acamprosate to work?
- Does acamprosate cause weight gain?
- How does acamprosate work?
- Acamprosate vs naltrexone: How do they compare?
- Does acamprosate make you sick if you drink alcohol?
- How long does it take for acamprosate to work?
- Does acamprosate cause weight gain?
- How does acamprosate work?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions